rediff.com
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sales 853.27 655.20 658.29 599.55 433.42
Operating profit 139.94 91.90 113.72 113.71 71.49
Interest 0.99 3.61 3.80 5.35 7.29
Gross profit 201.02 148.77 152.17 139.52 64.37
EPS (Rs) 2.95 2.27 2.54 2.40 0.93
Annual  results in details
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Other income 62.07 60.48 42.25 31.16 0.17
Stock adjustment -7.25 -10.19 3.89 0.55 -5.63
Raw material 407.15 338.49 327.99 291.29 209.20
Power and fuel - - - - -
Employee expenses 77.19 56.09 60.46 54.64 48.51
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 236.24 178.91 152.23 139.35 109.85
Provisions made - - - - -
Depreciation 29.13 16.74 17.66 15.19 11.64
Taxation 38.13 29.17 30.52 25.95 14.82
Net profit / loss 133.76 102.87 103.99 98.38 37.90
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 45.32 45.32 40.93 40.93 40.93
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 16.40 14.03 17.27 18.97 16.49
GPM (%) 21.96 20.79 21.72 22.12 14.85
NPM (%) 14.61 14.37 14.84 15.60 8.74
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close